Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/15506
Full metadata record
DC FieldValueLanguage
dc.contributor.authorROBAEYS, Geert-
dc.contributor.authorGrebely, Jason-
dc.contributor.authorMauss, Stefan-
dc.contributor.authorBruggmann, Philip-
dc.contributor.authorMoussalli, Joseph-
dc.contributor.authorDe Gottardi, Andrea-
dc.contributor.authorSwan, Tracy-
dc.contributor.authorARAIN, Amber-
dc.contributor.authorKautz, Achim-
dc.contributor.authorStoever, Heino-
dc.contributor.authorWedemeyer, Heiner-
dc.contributor.authorSchaefer, Martin-
dc.contributor.authorTaylor, Lynn-
dc.contributor.authorBackmund, Markus-
dc.contributor.authorDalgard, Olav-
dc.contributor.authorPrins, Maria-
dc.contributor.authorDore, Gregory J.-
dc.date.accessioned2013-09-25T13:13:05Z-
dc.date.available2013-09-25T13:13:05Z-
dc.date.issued2013-
dc.identifier.citationCLINICAL INFECTIOUS DISEASES, 57, p. S129-S137-
dc.identifier.issn1058-4838-
dc.identifier.urihttp://hdl.handle.net/1942/15506-
dc.description.abstractIn the developed world, the majority of new and existing hepatitis C virus (HCV) infections occur among people who inject drugs (PWID). The burden of HCV-related liver disease in this group is increasing, but treatment uptake among PWID remains low. Among PWID, there are a number of barriers to care that should be considered and systematically addressed, but these barriers should not exclude PWID from HCV treatment. Furthermore, it has been clearly demonstrated that HCV treatment is safe and effective across a broad range of multidisciplinary healthcare settings. Given the burden of HCV-related disease among PWID, strategies to enhance HCV assessment and treatment in this group are urgently needed. These recommendations demonstrate that treatment among PWID is feasible and provides a framework for HCV assessment, management, and treatment. Further research is needed to evaluate strategies to enhance assessment, adherence, and SVR among PWID, particularly as new treatments for HCV infection become available.-
dc.language.isoen-
dc.publisherOXFORD UNIV PRESS INC-
dc.subject.otherdrug users; injecting; injection; guidelines; HCV; HIV-
dc.subject.otherImmunology; Infectious Diseases; Microbiology-
dc.titleRecommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs-
dc.typeJournal Contribution-
dc.identifier.epageS137-
dc.identifier.spageS129-
dc.identifier.volume57-
local.format.pages9-
local.bibliographicCitation.jcatA1-
dc.description.notes[Robaeys, Geert; Arain, Amber] Ziekenhuis Oost Limburg, Dept Gastroenterol & Hepatol, B-3600 Genk, Belgium. [Robaeys, Geert] Hasselt Univ, UZ Leuven, Dept Hepatol, Louvain, Belgium. [Robaeys, Geert; Arain, Amber] Hasselt Univ, Limburg Clin Res Program, Fac Med & Life Sci, Louvain, Belgium. [Grebely, Jason; Dore, Gregory J.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia. [Mauss, Stefan] Ctr HIV & Hepatogastroenterol, Dusseldorf, Germany. [Bruggmann, Philip] Arud Ctr Addict Med, Zurich, Switzerland. [Moussalli, Joseph] Hop La Pitie Salpetriere, Paris, France. [Moussalli, Joseph] Univ Paris 06, Paris, France. [De Gottardi, Andrea] Univ Bern, Inselspital, Clin Visceral Surg & Med, CH-3010 Bern, Switzerland. [Swan, Tracy] Treatment Act Grp, New York, NY USA. [Kautz, Achim] European Liver Patients Assoc, Cologne, Germany. [Stoever, Heino] Univ Appl Sci, Inst Addict Res, Frankfurt, Germany. [Wedemeyer, Heiner] Leibniz Univ Hannover, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany. [Schaefer, Martin] Kliniken Essen Mitte, Dept Psychiat Psychotherapy & Addict Med, Essen, Germany. [Schaefer, Martin] Charite Univ Med Berlin, Dept Psychiat & Psychotherapy CCM, Berlin, Germany. [Taylor, Lynn] Brown Univ, Dept Med, Providence, RI 02912 USA. [Backmund, Markus] Univ Munich, Munich, Germany. [Backmund, Markus] Praxiszentrum Tal Munich, Munich, Germany. [Dalgard, Olav] Akershus Univ Hosp, Dept Infect Dis, Lorenskog, Norway. [Prins, Maria] Univ Amsterdam, Acad Med Ctr, Dept Res, Cluster Infect Dis,Publ Hlth Serv Amsterdam, NL-1105 AZ Amsterdam, Netherlands. [Prins, Maria] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands. [Dore, Gregory J.] St Vincents Hosp, HIV Immunol Infect Dis Clin Serv Unit, Sydney, NSW 2010, Australia.-
local.publisher.placeCARY-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1093/cid/cit302-
dc.identifier.isi000322378900017-
item.fulltextNo Fulltext-
item.fullcitationROBAEYS, Geert; Grebely, Jason; Mauss, Stefan; Bruggmann, Philip; Moussalli, Joseph; De Gottardi, Andrea; Swan, Tracy; ARAIN, Amber; Kautz, Achim; Stoever, Heino; Wedemeyer, Heiner; Schaefer, Martin; Taylor, Lynn; Backmund, Markus; Dalgard, Olav; Prins, Maria & Dore, Gregory J. (2013) Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs. In: CLINICAL INFECTIOUS DISEASES, 57, p. S129-S137.-
item.contributorROBAEYS, Geert-
item.contributorGrebely, Jason-
item.contributorMauss, Stefan-
item.contributorBruggmann, Philip-
item.contributorMoussalli, Joseph-
item.contributorDe Gottardi, Andrea-
item.contributorSwan, Tracy-
item.contributorARAIN, Amber-
item.contributorKautz, Achim-
item.contributorStoever, Heino-
item.contributorWedemeyer, Heiner-
item.contributorSchaefer, Martin-
item.contributorTaylor, Lynn-
item.contributorBackmund, Markus-
item.contributorDalgard, Olav-
item.contributorPrins, Maria-
item.contributorDore, Gregory J.-
item.validationecoom 2014-
item.accessRightsClosed Access-
crisitem.journal.issn1058-4838-
crisitem.journal.eissn1537-6591-
Appears in Collections:Research publications
Show simple item record

SCOPUSTM   
Citations

81
checked on Sep 2, 2020

WEB OF SCIENCETM
Citations

93
checked on Mar 21, 2024

Page view(s)

92
checked on May 30, 2023

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.